Member Info for Cliostock

I really can’t see there being a minimum royalty trigger in a situation where it is Croda using our IP, I don’t see the necessity for it. If Croda sold £10 worth of Zenakine in a quarter there would be nothing stopping them sending us £1. I really can’t see why any SBTX representatives would accept this as a contract term or why it would benefit Croda in including it when they only have to pay the money out later anyway. I think the clue is in SA saying it’s a ‘sample’ number that turns into sales as they formulate. I think SA is counting as sales what Croda has given away for free. I still believe good royalties will come from the back of those samples proving efficacy and turning into product launches, but I think SA has yet again been far too optimistic. Another mere bump in the road, SP will rise again and without SA’s land mines hopefully the ride will be smoother following the results of the investigation.

Laura, MD neither knew the CEO or was an activist investor. I believe he is circa 80 years old and has a history of making large investments which go on to quadruple or more in value. We believe his average to be around 17p.

Re the TR1’s, he has previously submitted them by post. Given the news about Royal Mail delaying letters, if MD was to wait until the last minute, then pop his TR1 in second class, it would already take a few extra days to get to the company, and a lot is probably happening in that time. Plus, who is picking it up and opening it given all the chaos which is probably happening within the company!

I think you’ve been most successful at initiating action Nick, I suggest you get involved!

For all the newbies here, this share was down to approx 5p intraday during covid during times of uncertainty and went up in multiples from there. Underlying there is some very exciting technology and the right directors could certainly help with some household products coming to market, both through Croda, Superdrug and in house. I personally wouldn’t recommend anyone to ‘invest’ until we have any more information but if you are hoping for a multi bagger and happy with the risk then it could certainly stabilise and see you double your money or more.

I’ll be here until it recovers now, but expect this to blow over as other market fears have in the past and get to at least the 30p sort of area.

Amazing how many new names are circling the company, talking like experts but getting basic information wrong. “Ashmore” lol.

There is only one recently acquired shareholder I’m interested in hearing the opinion of, and that is Mark Dixon. Coupled with his (rumoured) associate David Brierwood they own over a quarter of the company. Mark Dixon has spent circa £10M buying shares in the past couple of months and David Brierwood has previously lent the company money to assist with an acquisition.

There is very little individual posters on the boards can do to influence things but these two guys can, and no doubt will, be intervening. Alyson Levitt is new to the board and is a portfolio non exec specialising in audit and risk. These people will be working to straighten out the affairs and restore order and value.

I for one think it’s too far down to sell and no sense in buying, I have enough SBTX shares to benefit from a recoup. Time for LTH’s to tune out from the noise and see what the people on our side manage to do for themselves, which benefits us. GLA.

I’m sure Mr Dixon and Mr Brierwood have much more sway with the board than any of us, and probably more of a sense of what needs to be done to restore value, so I’m happy to hold my shares and let them do the talking to straighten things out. A decision I’m sure I’ll regret if anything untoward comes out. But on the other hand will be looking to buy at the depressed prices if we find out it was just Ashman being a plonker. I do believe that a new CEO more interested in shareholder value than secretive empire building would be in a great position to raise the share price above where it was before at 20p-ish, to a higher level. Time will tell, again we are in the dark without even a glow from the flames under Stuart’s boiling pans to guide us!

Yes agreed.

Lanky lad I think that’s another fair point for the argument that the conduct is not finance related. Geoff Bell didn’t stick around and neither did Simon Hewitson. There is anecdotal evidence that Manprit Randhawa might have had other irons in the fire but on his wage for such an easy role I find it hard to believe he would think the grass is greener elsewhere. My wager is on something personnel related. Let’s hope the investigation is over quickly and outcome released.

Another thanks to Shychap; a case of right place, right time given your casual access to MD, but it has provided much reassurance. I live in hope that the frustrations and negativities we have all experienced recently are alleviated with a new chief. We need someone who wants to play with a straight bat, not a manipulator like Ashman, to run this company for the benefit of shareholders. Onwards and upwards. Going to start setting the morning alarm early enough to see RNS’s before the market opens, hoping for a top up opportunity if there is a release that states the conduct is isolated to Ashman himself and doesn’t affect the financials or trading. Also thanks to Toyin for sounding out the wording and spearheading the strong argument that the issues are not financial. Until we are told otherwise, our cash position should be very healthy.

Well that was a surprise. Suspect we’re in for a bumpy few months but ultimately anyone that was going to vote against the reelection of Ashman at the AGM should be pleased. Same company, same deal with Croda, much reduced wage bill. Let’s see who the new CEO is and let’s get behind them to reveal the extent of any value that SA may or may not have created whilst in post.

So simple Toyin, yet seemingly so hard!

I think Tom’s quality of information and integrity is in the same ballpark as SA’s. I can’t believe anyone still subscribes.

Thanks for the information Shychap.

Interesting to see the advert shouts about the active ingredient Zenakine, and also that it is playing heavily into the sleep theme. We know there is so much more to the product than that; fundamental, groundbreaking benefits which are untapped by the Morpheus product. How I’d love to be a fly on the wall in some of these meeting rooms!

Ox, it’s a shame it hasn’t been done already. With the formulation capabilities within SBTX and BTS and the packaging and marketing capabilities within DT, at the very most we would have needed a project manager on 40k to pull that together.

That’s kind of my point Aquae. We have launched in circa 200 Superdug stores, it is naturally fair to assume some product has been sold, if that’s as close as we can get, without the website. Although I must say the grass roots sleuthing is a welcome change from the ego-club arguing over who is king diddly. I don’t mean to discourage. It’s all filling time until these half year results come out.

Aquae, don’t you think that there are simply too many unknowns to infer anything useful?

Exactly my thoughts Disco-Dan.

PGlancy where did that information come from about the OPTI share offers?

Net… May.